Endpoints at #JPM25 - January 13-14, 2025 - San Francisco
In the biopharma world, the new year doesn’t start on January 1 — it starts when the industry descends on San Francisco for JPM.
Endpoints News – Biotech and pharma business news, with a focus …
Biotech and pharma business news, with a focus on the science, people and money that drive the industry.
Developing your new medicine in Japan faster - events.endpts.com
2024年11月14日 · Getting new medicines developed in Japan is now easier, thanks to regulatory streamlining and changes in the pricing system. Senior Japanese government officials and industry leaders join Endpoints News to discuss the details. Join us to learn how your company can benefit and bring your drug to market faster.
Eli Lilly, Pfizer stress independence of telehealth partners in ...
2024年12月3日 · In response to lawmakers' concerns, Pfizer and Eli Lilly said last week that they do not influence telehealth partners and their clinicians to prescribe their brand-name drugs.
Novartis buys Kate Therapeutics in $1.1B deal, eyes more bolt-on …
2024年11月21日 · Novartis is acquiring Kate Therapeutics for $1.1 billion, focusing on gene therapy and neuroscience. CEO Vas Narasimhan and CFO Harry Kirsch indicate future M&A deals will likely stay under $3 ...
Applied Therapeutics CEO steps down after rare disease drug …
2024年12月20日 · Applied Therapeutics CEO Shendelman exits; CFO Funtleyder becomes interim CEO after FDA rejects govorestat. Company withdraws EU application for rare disease drug.
Agenda: Endpoints at #JPM25 - events.endpts.com
2025年1月13日 · The 2025 dealmaking outlook What’s on the horizon for dealmaking in 2025, with a new administration and a changing economic and antitrust environment? Industry leaders will give their outlook on the year, their priorities and what they're watching for in the market.
Pfizer projects stability for 2025 amid turbulence in DC
2024年12月17日 · Pfizer projects flat 2025 revenue, plans more cost cuts and R&D focus under CSO Chris Boshoff, while CEO Bourla addresses Trump meeting and maintains dividend commitment.
Deerfield to buy Singular Genomics, beating out rival
2024年12月23日 · An affiliate of Deerfield Management Company will acquire Singular Genomics Systems, ending a months-long competition between two suitors that bid up the price of the DNA sequencing company.
AbbVie makes another small I&I acquisition, buying Nimble for …
2024年12月13日 · In an attempt to continue its I&I dominance beyond Humira, Skyrizi and Rinvoq, AbbVie is buying up another small autoimmune startup.